Immunic Therapeutics
- Business Model
- B2B
- Website
- immunic-therapeutics.com
About
Immunic Therapeutics (Immunic, Inc.) is a publicly traded clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies for autoimmune and inflammatory diseases. The company files with the SEC and maintains active investor relations.
Summary
Immunic Therapeutics is a Biotech company.
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Warner ChilcottClosed
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
inVentiv HealthAcquired
Biopharmaceutical services company
Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Altos Labs
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022